[1]
Knezović, K. et al. 2022. Use of Bevacizumab and Aflibercept in the Treatment of Diabetic Macular Edema: Cost-effectiveness Analysis. Annals of Biomedical and Clinical Research. 1, 1 (Jul. 2022), 28–33.